Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

You don’t have to spend more than $50 on a great USB-C dock for your Switch 2

April 11, 2026

TitanPlay Highlights Early-Stage Approach to Responsible Gambling in Ontario

April 11, 2026

The Audacity is a new show making fun of tech brosThe new show making fun of tech bros

April 11, 2026

Is the ‘Holy Grail of batteries’ finally ready to bless us with its presence?

April 11, 2026

Cookiy Introduces a User Research Suite That Enables Any AI to Talk to Real People

April 11, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » United States Sleep Apnea Devices Market Research and Competitive Analysis 2025-2033 Featuring Carefusion, Somnomed, ResMed, Koninklijke Philips, Compumedics, Natus Medical, Teleflex, Fisher & Paykel
Press Release

United States Sleep Apnea Devices Market Research and Competitive Analysis 2025-2033 Featuring Carefusion, Somnomed, ResMed, Koninklijke Philips, Compumedics, Natus Medical, Teleflex, Fisher & Paykel

By News RoomMarch 13, 20256 Mins Read
United States Sleep Apnea Devices Market Research and Competitive Analysis 2025-2033 Featuring Carefusion, Somnomed, ResMed, Koninklijke Philips, Compumedics, Natus Medical, Teleflex, Fisher & Paykel
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, March 13, 2025 (GLOBE NEWSWIRE) — The “United States Sleep Apnea Devices Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering.

The United States Sleep Apnea Device Market is anticipated to grow from US$ 2.16 Billion in 2024 to a phenomenal US$ 4.02 Billion by 2033, exhibiting a strong CAGR of 7.14% during 2024-2033, fueled by rising cases of sleep apnea, innovative diagnostic and therapeutic devices, and improved awareness of sleep-related health risks among the populace.

The expanding prevalence of sleep apnea, compounded by lifestyle drivers such as obesity and lack of physical activity, is driving a greater need for efficient diagnostic and treatment devices. With close to 30 million Americans suffering from this condition, there has been a huge increase in the demand for Continuous Positive Airway Pressure (CPAP) machines, Bi-level Positive Airway Pressure (BiPAP) systems, and other such technologies. Increased public information campaigns and innovative research into the health of sleep are contributing in significant ways towards greater knowledge and acceptance of these essential sleep apnea machines, ultimately leading towards their broader acceptance among sufferers.

Technological Advances in Sleep Apnea Devices

The progress of cutting-edge, portable, and easy-to-use devices has driven phenomenal growth in the market. Advanced features like auto-titrating CPAP devices, which dynamically adjust pressure for maximum comfort, and cloud-stored data that enables easy monitoring and analysis of patient improvement, are attracting more and more consumers.

Moreover, the focus on quiet operation is also improving user experience, keeping these devices more unobtrusive while in use. These revolutionary innovations not only increase accessibility but also enable patients with sleep apnea to be treated in the comfort of their own homes, ultimately leading to a deeper market penetration and better overall health outcomes.

Increased Emphasis on Home Healthcare

The increasing emphasis on home-based care, touted for its unmatched convenience and economic benefits, is largely driving the use of sleep apnea devices. This transition is amplified by the consolidation of telemedicine services, which, in combination with innovative diagnostic equipment used in the home such as portable sleep monitors, widens the accessibility of these key technologies. Individually and collectively, they enable a streamlined and effective solution to the management of sleep disorders, enabling patients to be attended to by good quality care provided from the comforts of their home.

High Cost of Devices and Restricted Reimbursement Policies

More sophisticated sleep apnea machines, particularly Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) equipment, are extremely expensive for many patients. The economic hardship is also further worsened by poor insurance coverage, which many times falls short of providing full compensation for all types of sleep apnea therapies. This lack of support not only deters people from investing in these vital devices but also represents a significant barrier to the wider growth of the market. Consequently, numerous patients are left to navigate a complicated environment of health requirements and financial limitations, preventing them from accessing critical respiratory assistance.

Lack of Awareness and Diagnosis

In spite of the prevalence of sleep apnea, a large number of people affected by this condition are unaware and undiagnosed. This is mainly due to a lack of awareness regarding the condition, which causes most people to underestimate the severe health consequences associated with untreated sleep apnea, such as numerous cardiovascular diseases. This diagnostic gap in the early detection of sleep apnea not only affects the health of the individuals but also inhibits the growth and development of the market for sleep apnea devices, preventing innovation that can enhance patient outcomes and quality of life.

United States CPAP Sleep Apnea Devices Market

The CPAP segment dominates the U.S. market. It is the standard for the treatment of obstructive sleep apnea (OSA). These machines supply continuous airflow to keep airways open during sleep, without interruptions. Auto-adjusted pressure settings and portable models make CPAP machines suitable for various patients. Increased awareness and physician prescriptions continue to grow the market.

United States BiPAP Sleep Apnea Devices Market

BiPAP (Bi-level Positive Airway Pressure) machines are for patients who are experiencing trouble with CPAP therapy or require more pressure support. They offer two pressure levels for inhaling and exhaling, which enhance comfort and compliance. Popular among patients with severe sleep apnea or other respiratory conditions, BiPAP machines are gaining popularity due to their versatility and growing insurance coverage.

United States Oximeter Sleep Apnea Devices Market

Oximeters are an integral part of the monitoring of oxygen saturation levels in sleep apnea patients. Simple to use and noninvasive, they provide real-time feedback to assess the efficacy of treatment. The growing application of oximeters as a component of CPAP devices to improve therapy monitoring enhances the popularity of this segment. Growing awareness of sleep monitoring among health-conscious individuals further fuels demand.

United States Sleep Apnea Screening Devices Market

Screening devices, including sleep monitors and diagnostic devices, play a vital role in early diagnosis of sleep apnea. The devices enable patients to be screened at home, reducing costs and enhancing accessibility. With the healthcare industry emphasizing preventive care, demand for screening devices is likely to increase exponentially in America.

United States Sleep Apnea Devices Clinics & Hospitals Market

Hospitals and clinics are the key centers for the diagnosis and treatment of sleep apnea. They provide extensive testing services, state-of-the-art therapy devices, and sleep specialist consultations. Increased focus on enhancing sleep health and access to state-of-the-art technologies positions hospitals and clinics as key players in the sleep apnea devices market.

Company Analysis: Key Person, Recent Developments, Product Portfolio- SWOT Analysis, Revenue

  • Carefusion Corp. (Part of Becton, Disckinson & Company)
  • Somnomed
  • ResMed Inc.
  • Koninklijke Philips N.V.
  • Compumedics
  • Natus Medical Incorporated
  • Teleflex Incorporated
  • Fisher &Paykel Healthcare

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2024 – 2033
Estimated Market Value (USD) in 2024 $2.16 Billion
Forecasted Market Value (USD) by 2033 $4.02 Billion
Compound Annual Growth Rate 7.1%
Regions Covered United States

Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities

5. United States Sleep Apnea Devices Market

6. Share Analysis
6.1 By Products Types
6.1.1 By Therapeutics
6.1.2 By Diagnostics
6.2 By End User

7. Product Types- United States Sleep Apnea Devices Market
7.1 Therapeutic Devices
7.1.1 CPAP Sleep Apnea Therapeutic Devices
7.1.2 Auto CPAP Sleep Apnea Therapeutic Devices
7.1.3 BiPAP Sleep Apnea Therapeutic Devices
7.1.4 Adaptive Servo-Ventilation (ASV)
7.2 Diagnostic Devices
7.2.1 Polysomnography Devices (PSG)
7.2.2 Oximeter
7.2.3 Actigraphy Monitoring Device
7.2.4 Respiratory Polygraph
7.2.5 Sleep Apnea Screening Device

8. End User – United States Sleep Apnea Devices Market
8.1 Sleep Laboratories, Clinics & Hospitals
8.2 Home Care Settings/Individuals

9. Porter’s Five Forces Analysis
9.1 Bargaining Power of Buyers
9.2 Bargaining Power of Suppliers
9.3 Degree of Competition
9.4 Threat of New Entrants
9.5 Threat of Substitutes

10. SWOT Analysis
10.1 Strength
10.2 Weakness
10.3 Opportunity
10.4 Threats

11. Key Players Analysis

For more information about this report visit https://www.researchandmarkets.com/r/l22vqy

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • U.S. Sleep Apnea Devices Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

TitanPlay Highlights Early-Stage Approach to Responsible Gambling in Ontario

Cookiy Introduces a User Research Suite That Enables Any AI to Talk to Real People

Changing Life & Destiny Conference to Honor Dylan Gemelli with the CLD 2026 Wellness Educator Award

Umbrella Lab Announces RUO Documentation And Traceability Update For MSCs Exosomes

Crypto News: AlphaPepe Announces $800k Raised While Bitcoin Price Prediction Targets $80K Breakout After Global Ceasefire

4th EXEED Global Dealer Annual Conference Gathers Global Partners; RX FL, EX8, EX6 & ES GT Interior to Premiere at Auto China

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2026

Dakila launches Manifesto Video and reveals Safari Brasil to the world as a new destination in the living Amazon

Toll Brothers Announces Model Grand Opening at Sereno Canyon – Enclave Collection in Scottsdale, Arizona

Editors Picks

TitanPlay Highlights Early-Stage Approach to Responsible Gambling in Ontario

April 11, 2026

The Audacity is a new show making fun of tech brosThe new show making fun of tech bros

April 11, 2026

Is the ‘Holy Grail of batteries’ finally ready to bless us with its presence?

April 11, 2026

Cookiy Introduces a User Research Suite That Enables Any AI to Talk to Real People

April 11, 2026

Latest News

Changing Life & Destiny Conference to Honor Dylan Gemelli with the CLD 2026 Wellness Educator Award

April 11, 2026

Umbrella Lab Announces RUO Documentation And Traceability Update For MSCs Exosomes

April 11, 2026

Ontario failed to collect nearly $10M owed by alleged animal abusers: documents

April 11, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version